H2AZ1 and hepatocellular carcinoma: We initially investigated mutations and copy number alterations of H2AFZ in the TCGA-LIHC cohort using c-Bioportal and no alteration of H2AFZ copy number was found (Supplementary Figure 1), indicating that increased H2AFZ mRNA in HCC was not associated with the alteration of H2AFZ copy number.